Literature DB >> 14674897

Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).

A Katalinic1, U Kunze, T Schäfer.   

Abstract

BACKGROUND: Population-based figures on skin cancer are essential for a realistic assessment of the personal disease burden, prevention modes and the need for caring. The Robert Koch Institute in Germany estimates the incidence of melanoma skin cancer as seven cases in 100 000 persons (age-standardized by the European standard rate). Population-based studies presumably show higher incidence rates of 10-16 cases in 100 000 persons. Few data exist for non-melanoma skin cancer (NMSC) as this is not systematically registered in Germany.
OBJECTIVES: To present the first population-based results from the Schleswig-Holstein (Germany) Cancer Registry on incidence, stage distribution, clinical types and localization of skin cancer and to compare the results with other studies.
METHODS: The Cancer Registry of the Bundesland Schleswig-Holstein with 3500 registering institutions, 100 of which are dermatological institutions, investigates all notifiable incident cancer cases according to international standards. From the recorded data all melanoma and NMSC cases were identified and evaluated.
RESULTS: Between 1998 and 2001, 1784 malignant melanoma (MM) and 12 956 NMSC cases underwent diagnostic and analytical evaluation. For MM, age-standardized incidence rates were 12.3 and 14.8 in 100 000 men and women, respectively, and the mean age of men was greater than that of women (56.6 vs. 54.9 years, P < 0.05). Superficial spreading melanoma was the most frequent clinical type (39.1%). The tumours were predominantly located on the trunk in men (46.8%) in contrast to leg and hip in women (39.5%). For NMSC, the age-standardized incidence rates were 100.2 and 72.6 in 100 000 men and women, respectively. More than 80% of all tumours were basal cell carcinoma.
CONCLUSIONS: The first population-based data from Schleswig-Holstein on the characteristics (age, sex, histological subtypes, localization and stage) of skin tumours agree well with the existing literature and may thus be regarded as representative. However, markedly higher incidences for MM and NMSC in the north of Germany compared with other parts of the country were observed. As the incidence rates from the north of Germany fit well into the European geographical pattern, we assume no regional increase. Therefore, the official German estimates on cutaneous tumours may largely depend on regional factors and may not be regarded as representative for all regions in Germany.

Entities:  

Mesh:

Year:  2003        PMID: 14674897     DOI: 10.1111/j.1365-2133.2003.05554.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  59 in total

1.  Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.

Authors:  Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-14       Impact factor: 4.553

2.  [Epidemiology of occupational skin cancer due to UV-irradiation].

Authors:  T L Diepgen; H Drexler; J Schmitt
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

3.  [Treatment results after surgery for basal cell carcinomas of the head and neck region taking into consideration various reconstruction techniques].

Authors:  J-U Piesold; S Vent; R Krüger; H Pistner
Journal:  Mund Kiefer Gesichtschir       Date:  2005-05

4.  'The nodule that disappeared' spontaneous regression of an eyelid noduloulcerative lesion mimicking the features of a basal cell carcinoma.

Authors:  Tafadzwa Young-Zvandasara; Magdalena Popiela; Garry Shuttleworth
Journal:  BMJ Case Rep       Date:  2015-01-29

5.  Triterpenoid corosolic acid modulates global CpG methylation and transcriptome of tumor promotor TPA induced mouse epidermal JB6 P+ cells.

Authors:  Rasika R Hudlikar; Davit Sargsyan; Renyi Wu; Shan Su; Meinizi Zheng; Ah-Ng Kong
Journal:  Chem Biol Interact       Date:  2020-03-03       Impact factor: 5.192

6.  Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck.

Authors:  Ulrich Strassen; Benedikt Hofauer; Christian Jacobi; Andreas Knopf
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

7.  Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.

Authors:  Geffen Kleinstern; Abdul Rishi; Sara J Achenbach; Kari G Rabe; Neil E Kay; Tait D Shanafelt; Wei Ding; Joe F Leis; Aaron D Norman; Timothy G Call; James R Cerhan; Sameer A Parikh; Christian L Baum; Susan L Slager
Journal:  J Am Acad Dermatol       Date:  2020-07-16       Impact factor: 11.527

Review 8.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

9.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

Review 10.  [Cutaneous squamous cell carcinoma: a review with consideration of special patient groups].

Authors:  U Hillen; M Ulrich; M Alter; J C Becker; R Gutzmer; U Leiter; A Lonsdorf; A Messerschmidt; C Ulrich
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.